Egypt vs Grenada: Cause of death, by non-communicable diseases, ages 15-59, male
Egypt
50.6%
in 2021
Grenada
51.3%
in 2021
Egypt rank
89th
Grenada rank
88th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Egypt
- Grenada
How they compare
Grenada currently reports 51.3% against 50.6% in Egypt, a difference of 0.7%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Egypt ahead.
Egypt ranks 89th and Grenada ranks 88th of 185 countries.
Across the 3 decades both report, Egypt averaged higher in 2 and Grenada in 1.
Head to head by decade
| Decade | Egypt | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 78.8% | 69.1% | 9.6% | Egypt |
| 2010s | 80.4% | 70.8% | 9.7% | Egypt |
| 2020s | 56.3% | 62.0% | 5.7% | Grenada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Egypt or Grenada?
- Grenada, at 51.3% against 50.6% in Egypt as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Egypt and Grenada?
- 0.7%, with Grenada ahead.
- How many years of comparable data are there for Egypt and Grenada?
- 6 years are reported by both, from 2000 to 2021.
- How do Egypt and Grenada rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Egypt ranks 89th and Grenada ranks 88th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.